Advertisement Chinese FDA Renews Jiangbo's GMP Certificate - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Chinese FDA Renews Jiangbo’s GMP Certificate

Jiangbo Pharmaceuticals (Jiangbo) has reported that one of its factories in China has received a renewal of its Good Manufacturing Practices Certificate for Pharmaceutical Products (GMP Certificate) from the State Food and Drug Administration (SFDA) for its tablets and granules.

The company said that the new certificate will be valid until November 2014. Jiangbo has another GMP certified factory to produce traditional chinese medicines in tablets, granules, pills, mixture, syrup, and concentrated decoction.

According to the National Medicine Administration Law of the People’s Republic of China, all pharmaceutical manufacturers are required to pass an examination every five years to renew their GMP Certificates.

Reportedly, in November 2009, the examination committee visited the company and conducted a review of its supply chain management practices, including quality control of raw materials, its manufacturing processes, and the inspection and acceptance of its finished products.

Wubo Cao, CEO of Jiangbo, said: “We are pleased to obtain the renewal of our GMP Certificate, which reinforces Jiangbo’s commitment to providing the highest quality pharmaceutical products to patients.”